Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis
File version
Accepted Manuscript (AM)
Author(s)
Wee, BA
Duplancic, C
Ramsay, KA
Dave, KA
Ballard, E
Wainwright, CE
Grimwood, K
Sidjabat, HE
Whiley, DM
Beatson, SA
Kidd, TJ
Bell, SC
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Background: Antimicrobial resistance in cystic fibrosis (CF) Pseudomonas aeruginosa airway infection is complex and often attributed to chromosomal mutations. How these mutations emerge in specific strains or whether particular gene mutations are clinically informative is unclear. This study focused on oprD, which encodes an outer membrane porin associated with carbapenem resistance when it is downregulated or inactivated. Aim: Determine how mutations in oprD emerge in two prevalent Australian shared CF strains of P. aeruginosa and their clinical relevance. Methods: The two most common shared CF strains in Queensland were investigated using whole genome sequencing and their oprD sequences and antimicrobial resistance phenotypes were established. P. aeruginosa mutants with the most common oprD variants were constructed and characterised. Clinical variables were compared between people with or without evidence of infection with strains harbouring these variants. Results: Frequently found nonsense mutations arising from a 1-base pair substitution in oprD evolved independently in three sub-lineages, and are likely major contributors to the reduced carbapenem susceptibility observed in the clinical isolates. Lower baseline FEV %predicted was identified as a risk factor for infection with a sub-lineage (odds ratio=0.97; 95% confidence interval 0.96-0.99; p<0.001). However, acquiring these sub-lineage strains did not confer an accelerated decline in FEV nor increase the risk of death/lung transplantation. Conclusions: Sub-lineages harbouring specific mutations in oprD have emerged and persisted in the shared strain populations. Infection with the sub-lineages was more likely in people with lower lung function, but this was not predictive of a worse clinical trajectory. 1 1
Journal Title
Journal of Cystic Fibrosis
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2021 European Cystic Fibrosis Society. Published by Elsevier Ltd. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.
Item Access Status
Note
This publication has been entered in Griffith Research Online as an advanced online version.
Access the data
Related item(s)
Subject
Clinical sciences
Antimicrobial resistance
Clinical outcomes
Cystci fibrosis
OPRD
Pseudomonas aeruginosa
Persistent link to this record
Citation
Sherrard, LJ; Wee, BA; Duplancic, C; Ramsay, KA; Dave, KA; Ballard, E; Wainwright, CE; Grimwood, K; Sidjabat, HE; Whiley, DM; Beatson, SA; Kidd, TJ; Bell, SC, Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis, Journal of Cystic Fibrosis, 2021